In contrast, corticosteroid treatment is generally effective in HOIL‐1 deficiency whereas anti‐TNF treatment in these patients is not (Boisson et al, 2012). This evidence concerns the gene RBCK1 and hyperinsulinemic hypoglycemia, familial, 4.